19-38915623-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017827.4(SARS2):c.1540C>G(p.Gln514Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017827.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARS2 | ENST00000221431.11 | c.1540C>G | p.Gln514Glu | missense_variant | Exon 16 of 16 | 1 | NM_017827.4 | ENSP00000221431.6 | ||
ENSG00000269547 | ENST00000599996.1 | c.1747C>G | p.Gln583Glu | missense_variant | Exon 20 of 20 | 2 | ENSP00000472465.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1540C>G (p.Q514E) alteration is located in exon 16 (coding exon 16) of the SARS2 gene. This alteration results from a C to G substitution at nucleotide position 1540, causing the glutamine (Q) at amino acid position 514 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.